1Gallo RL, Granstein RD, Kang S, Mannis M, Steinhoff M, Tan J, et al. Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol 2018;78:148-55.
2Jones DA. Rosacea, reactive oxygen species, and azelaic acid. J Clin Aesthet Dermatol 2009;2:26-30.
3Woo YR, Lim JH, Cho DH, Park HJ. Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition. Int J Mol Sci 2016;17:1562.
4Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol 2013;69:15-26.
5Vemuri RC, Gundamaraju R, Sekaran SD, Manikam R. Major pathophysiological correlations of rosacea: a complete clinical appraisal. Int J Med Sci 2015;12:387-96.
6Erbağcı Z. Rozasea: Sınıflama ve Etyopatogenezde Son Görüşler. Türkiye Klinikleri J Dermatol 2005;15:105-16.
7Baima B, Sticherling M. Demodicidosis revisited. Acta Derm Venereol 2002;82:3-6.
8Roihu T, Kariniemi AL. Demodex mites in acne rosacea. J Cutan Pathol 1998;25:550-2.
9Basta-Juzbasic A, Subic JS, Ljubojevic S. Demodex folliculorum in development of dermatitis rosaceiformis steroidica and rosacea-related diseases. Clin Dermatol 2002;20:135-40.
10Jansen T, Kastner U, Kreuter A, Altmeyer P. Rosacea-like demodicidosis associated with acquired immunodeficiency syndrome ( case reports). Br J Dermatol 2001;144:139-42.
11Stephen MP, Thomas JH, Steven LD. Pustular folliculitis associated with Demodex folliculorum. J Am Acad Dermatol 1986;15:1159-62.
12Forstinger C,Kitler H,Binder M. Treatment of rosacea-like demodecidosis with oral ivermectin and topical permethrin cream. J Am Acad Dermatol 1999;41:775-7.
13Rufli T, Mumcuoğlu Y. The hair follicle mites D. folliculorum and D. brevis: biology and medical importance. Dermatology 1981;162:1-11.
14Bonnar E, Eustace P, Powell FC. The Demodex mite population in rosacea. J Am Acad Dermatol 1993;28:443-8.
15Özçelik S. Parazitoloji’de artropod hastalıkları ve vektörler. Editörler, Özcel MA, Daldal N. İzmir: Ege Üniversitesi Basımevi; 1997.s.339-62.
16Erbağcı Z, Özgöztaşı O. The significance of Demodex folliculorum density in rosacea. Int J Dermatol 1998;37421-5.
17Isa NHM, Loong LW, Fang GH, Mohamad AM, Razali N, Rani NR, et al. Demodicosis among university medical students in Malaysia and the effects of facial cleanser and moisturizer usage. S Asian J Trop Med Public Health 2011;42:1375-80.
18Roihu T, Kariniemi AL. Demodex mites in acne rosacea. J Cutan Pathol 1998;25:550-2.
19Forton F, Seys B. Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy. Br J Dermatol 1993;128:650-9.
20Abd-El-Al AM, Bayoumy AM, Abou Salem EA. A studyon Demodex folliculorum in rosacea. J Egypt S Parasitol 1997;27:183-95.
21Sibenge S, Gawkrodger DJ. Rozasea: a study of clinical patterns, blood flow, and the role of DF. J Am Acad Dermatoll 1992;26:590-3.
22Cengiz ZT, Yılmaz H, Özkol HU, Ekici A, Ödemiş N. Yüzüncü Yıl Üniversitesi Dursun Odabaş Tıp Merkezi Parazitoloji Laboratuarına Başvuran Hastalarda Demodex sp.’nin Prevalansı. Turkiye Parazitol Derg 2014;38:9-11.
23Yücel A, Yilmaz M. Rosacea Ön Tanılı Hastalarda Demodex folliculorum ve Demodex brevis Yaygınlığının Araştırılması. Türkiye Parazitol Derg 2013;37:195-8.
24Turan N, Kapıcıoğlu Y, Saraç G. Akne Vulgaris ve Rozase Hastalarında Deri Sebum, pH ve Nem Değerlerinin Demodeks Enfestasyonuna Etkisi. Türkiye Parazitol Derg 2017;41:143-7.
25Georgala S, Katoulis AC, Kylafis GD, Koumantaki-Mathioudaki E, Georgala C, Aroni K. Increased density of DF and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea. JEADV 2001;15:441-4.